๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Surgical management of early stage central (hilar) and peripheral nonsmall cell lung carcinoma

โœ Scribed by Yoh Watanabe; Shinya Murakami; Makoto Oda; Yasuhiko Ohta; Shun-ichi Watanabe; Zensei Nozaki; Ryoichi Kamimura; Takeshi Kobayashi; Akitaka Nonomura; Hiroshi Minato


Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
159 KB
Volume
89
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

โœฆ Synopsis


BACKGROUND.

To the authors' knowledge, the definitions of early lung carcinoma used in Japan are not yet approved internationally. In the current study the diagnostic methods, pathology, and results of the surgical treatment of early hilar and peripheral nonsmall cell lung carcinoma cases defined by Japanese criteria are presented. Between 1977 and 1998, 43 patients with early hilar lung carcinoma were encountered. These patients constituted 14.5% of 200 hilar lung carcinoma patients who underwent resection during the same period. Between 1973 and 1998, there were 174 early peripheral lung carcinomas, which comprised 14.8% of 1173 peripheral lung carcinoma patients who underwent resection during the same period.

METHODS.

RESULTS.

The 5-year and 10-year survival rates of the early hilar lung carcinoma were 100% and 96.9%, respectively. The majority of the patients underwent bronchoplastic surgery, such as sleeve lobectomy and parenchymal-sparing surgery including seven sleeve segmentectomies and two second carinal resections. The effectiveness of the parenchymal-sparing resections was assessed by the conventional pulmonary function test as well as perfusion and ventilation scanning. There were 174 cases of peripheral early lung carcinoma among the 218 cases of peripheral lung carcinoma with tumor dimensions of ี… 2 cm. The cell types were 142 (81.6%) cases of adenocarcinoma, 18 (10.3%) cases of squamous cell carcinoma, and 14 (8%) cases of other cell types. These 174 patients comprised 14.8% of 1173 patients with peripheral nonsmall cell lung carcinoma who underwent surgery during the same period. The 5-year and 10-year survival rates for adenocarcinoma were 89.6% and 86.8%, respectively. The 5-year and 10-year survival rates for other cell types were both 71.8%. The overall 5-year and 10-year survival rates were 86.8% and 84.6%, respectively.

CONCLUSIONS.

Early lung carcinoma in both the hilar and peripheral regions, is curable if it is properly diagnosed and treated.


๐Ÿ“œ SIMILAR VOLUMES


Surgical management of early stage lung
โœ George L. Zorn III; Jonathan C. Nesbitt ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 109 KB ๐Ÿ‘ 1 views

For patients with lung cancer, the greatest hope for cure rests with patients with early stage disease. Surgery has been the standard of care for this group with the best 5-year survival of only 65% being achieved in patients with earliest pathologic Stage IA disease. Using strategies gained from th

Energy balance in nonsmall cell lung car
โœ Elisabeth W.ย H.ย M. Fredrix; Agnes J. Staal-van den Brekel; Emiel F.ย M. Wouters ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 85 KB ๐Ÿ‘ 2 views

In 53 nonsmall cell lung carcinoma (NSCLC) patients, resting energy expenditure (REE, measured by ventilated hood), energy intake (EI, determined

Overexpression of glut1 and glut3 in sta
โœ Mamoun Younes; Richard W. Brown; Mark Stephenson; Margaret Gondo; Philip T. Cagl ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 230 KB ๐Ÿ‘ 2 views

antibodies, the authors immunostained sections of formalin fixed, paraffin embedded tissues from 289 Stage I NSCLCs. The Kaplan-Meier survival method, the log Department of Pathology, Baylor College of rank test, and Fisher's exact test were used for statistical analysis. Medicine and the Methodist

Conventional clinicopathologic prognosti
โœ Kenji Suzuki; Kanji Nagai; Junji Yoshida; Mitsuyo Nishimura; Kenro Takahashi; To ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 109 KB ๐Ÿ‘ 2 views

## BACKGROUND. A number of prognostic factors have been reported for resected nonsmall cell lung carcinoma. None of them, however, has been reported to have greater prognostic impact than the pathologic TNM staging system. The authors evaluated 18 conventional clinicopathologic prognostic factors